The Journal of Immunology, Vol 150, Issue 12 5544-5555, Copyright © 1993 by American Association of Immunologists

ARTICLES

Four different classes of inhibitors of receptor-mediated endocytosis decrease tumor necrosis factor-induced gene expression in human endothelial cells

JR Bradley, DR Johnson and JS Pober
Boyer Center for Molecular Medicine, Yale University School of Medicine, New Haven, CT 06536-0812.

We have investigated the relationship between receptor-mediated endocytosis of TNF and TNF-induced gene expression in cultured human endothelial cells. Exposure of cells to hypertonicity, to cytoplasmic acidification, to treatment with phenylarsine oxide, or to treatment with primary amines such as putrescine or dansylcadaverine each inhibited receptor-mediated endocytosis by 30 to 75%, as measured by uptake of acetylated Dil-low density lipoprotein or of 125I-TNF. All four treatments also inhibited TNF-induced surface expression of ELAM-1 by 50 to 100%. Among these four treatments, only hypertonicity inhibited pinocytosis, as measured by uptake of fluorescein-BSA, and only phenylarsine oxide irreversibly inhibited protein synthesis, as measured by [35S]methionine incorporation. Notably, acidification or treatment with primary amines selectively inhibited the response to TNF, compared with the response to PMA, a drug that induces ELAM-1 through a pathway that bypasses surface receptors. Primary amines, which can be used for sustained periods under physiologic culture conditions without causing toxicity, were investigated further. Pretreatment of endothelial cells with 10 mM putrescine or 100 microM dansylcadaverine also inhibited TNF induction of ICAM-1 expression and VCAM-1 expression. Primary amines also inhibited IL-1-induced increases in ELAM-1, ICAM-1, and VCAM-1 measured 4 to 6 h after treatment and inhibited IFN-beta- and IFN-gamma-mediated induction of class I MHC molecules and IFN-gamma-mediated induction of class II MHC molecules measured 72 h after treatment with cytokine. Levels of mRNA encoding cytokine-inducible molecules were also selectively reduced by primary amines. A constitutively expressed surface molecule, gp96, was not affected in the same cells. These data are consistent with a role for receptor-mediated endocytosis in TNF-mediated gene induction and suggest a new potential target for anti-inflammatory therapy.

This article has been cited by other articles:

				C. S. M. Ferreira, M. C. Cheung, S. Missailidis, S. Bisland, and J. Gariepy Phototoxic aptamers selectively enter and kill epithelial cancer cells Nucleic Acids Res., February 1, 2009; 37(3): 866 - 876. [Abstract] [Full Text] [PDF]

				L. Sanderson, A. Khan, and S. Thomas Distribution of Suramin, an Antitrypanosomal Drug, across the Blood-Brain and Blood-Cerebrospinal Fluid Interfaces in Wild-Type and P-Glycoprotein Transporter-Deficient Mice Antimicrob. Agents Chemother., September 1, 2007; 51(9): 3136 - 3146. [Abstract] [Full Text] [PDF]

				S. Khan, M. S. Bijker, J. J. Weterings, H. J. Tanke, G. J. Adema, T. van Hall, J. W. Drijfhout, C. J. M. Melief, H. S. Overkleeft, G. A. van der Marel, et al. Distinct Uptake Mechanisms but Similar Intracellular Processing of Two Different Toll-like Receptor Ligand-Peptide Conjugates in Dendritic Cells J. Biol. Chem., July 20, 2007; 282(29): 21145 - 21159. [Abstract] [Full Text] [PDF]

				A. D'Alessio, R. S. Al-Lamki, J. R. Bradley, and J. S. Pober Caveolae Participate in Tumor Necrosis Factor Receptor 1 Signaling and Internalization in a Human Endothelial Cell Line Am. J. Pathol., April 1, 2005; 166(4): 1273 - 1282. [Abstract] [Full Text] [PDF]

				B Gao, T. Curtis, F. Blumenstock, F. Minnear, and T. Saba Increased recycling of (alpha)5(beta)1 integrins by lung endothelial cells in response to tumor necrosis factor J. Cell Sci., January 1, 2000; 113(2): 247 - 257. [Abstract] [PDF]

				S. J. Jones, E. C. Ledgerwood, J. B. Prins, J. Galbraith, D. R. Johnson, J. S. Pober, and J. R. Bradley TNF Recruits TRADD to the Plasma Membrane But Not the trans-Golgi Network, the Principal Subcellular Location of TNF-R1 J. Immunol., January 15, 1999; 162(2): 1042 - 1048. [Abstract] [Full Text] [PDF]

				B. Friedrichs, C. Muller, and R. Brigelius-Flohe Inhibition of Tumor Necrosis Factor-{alpha}– and Interleukin-1–Induced Endothelial E-Selectin Expression by Thiol-Modifying Agents Arterioscler Thromb Vasc Biol, December 1, 1998; 18(12): 1829 - 1837. [Abstract] [Full Text] [PDF]

				R. Hofmeister, K. Wiegmann, C. Korherr, K. Bernardo, M. Kronke, and W. Falk Activation of Acid Sphingomyelinase by Interleukin-1 (IL-1) Requires the IL-1 Receptor Accessory Protein J. Biol. Chem., October 31, 1997; 272(44): 27730 - 27736. [Abstract] [Full Text] [PDF]

				I. Spyridopoulos, A. B. Sullivan, M. Kearney, J. M. Isner, and D. W. Losordo Estrogen-Receptor–Mediated Inhibition of Human Endothelial Cell Apoptosis : Estradiol as a Survival Factor Circulation, March 18, 1997; 95(6): 1505 - 1514. [Abstract] [Full Text]

				N. Andrieu, R. Salvayre, J.-P. Jaffrézou, and T. Levade Low Temperatures and Hypertonicity Do Not Block Cytokine-induced Stimulation of the Sphingomyelin Pathway but Inhibit Nuclear Factor-kappaB Activation J. Biol. Chem., October 13, 1995; 270(41): 24518 - 24524. [Abstract] [Full Text] [PDF]